Q3 2024 Holdings
Filed 2024-11-13 | 43 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $317.7M | 6,291,851 | 26.3% |
| Geron Corp(GERN) | Common | 374163103 | $123.6M | 27,225,292 | 10.2% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $104.2M | 2,606,247 | 8.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $102.1M | 3,549,758 | 8.5% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $76.3M | 11,800,000 | 6.3% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $57.5M | 6,895,746 | 4.8% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $42.0M | 624,339 | 3.5% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $40.0M | 1,114,960 | 3.3% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $38.2M | 1,678,207 | 3.2% |
| Avadel Pharmaceuticals PLC | ADR | G29687103 | $35.2M | 2,684,109 | 2.9% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $20.1M | 1,105,454 | 1.7% |
| Zenas Biopharma Inc(ZBIO) | Common | 98937L105 | $20.0M | 1,183,260 | 1.7% |
| Erasca Inc(ERAS) | Common | 29479A108 | $18.4M | 6,756,756 | 1.5% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $18.0M | 1,505,862 | 1.5% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $17.1M | 1,552,685 | 1.4% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $15.2M | 591,882 | 1.3% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $13.6M | 2,797,704 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $13.1M | 1,277,818 | 1.1% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $12.9M | 1,650,440 | 1.1% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $12.1M | 1,122,471 | 1.0% |
| Abeona Therapeutics, Inc.(ABEO) | Common | 00289Y206 | $11.6M | 1,842,751 | 1.0% |
| Compass Pathway PLC(CMPS) | SPONSORED ADS | 20451W101 | $10.1M | 1,608,000 | 0.8% |
| Celcuity Inc(CELC) | Common | 15102K100 | $9.1M | 610,500 | 0.8% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $9.0M | 997,005 | 0.7% |
| Corvus Pharmaceuticals Holdings(CRVS) | Common | 221015100 | $7.9M | 1,497,268 | 0.7% |
| Regulus Therapeutics Inc(RGLS) | Common | 75915K309 | $7.9M | 5,000,000 | 0.6% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $7.3M | 4,034,522 | 0.6% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $6.5M | 3,556,023 | 0.5% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $6.5M | 6,173,439 | 0.5% |
| Adverum Biotechnologies, Inc.(AVU0) | Common | 00773U207 | $5.8M | 833,333 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $5.4M | 1,612,903 | 0.4% |
| Verastem Inc(VSTM) | Common | 92337C203 | $4.6M | 1,538,461 | 0.4% |
| Engene Holdings Inc.(ENGN) | Common | 29286M105 | $4.5M | 678,705 | 0.4% |
| Corbus Pharmaceuticals Holdings(CRBP) | Common | 21833P301 | $3.4M | 166,794 | 0.3% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $2.3M | 3,521,291 | 0.2% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $1.9M | 2,956,110 | 0.2% |
| Unicycive Therapeutics | Common | 90466Y103 | $1.8M | 4,470,152 | 0.2% |
| Aligos Therapeutics Inc(ALGS) | Common | 01626L204 | $1.2M | 141,879 | 0.1% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.2M | 388,144 | 0.1% |
| DBV Technologies SA | SPONSORED ADS | 23306J200 | $948.1K | 1,354,437 | 0.1% |
| Q32 Bio Inc.(QTTB) | Common | 746964105 | $917.3K | 20,559 | 0.1% |
| Tenax Therapeutics Inc(TENX) | Common | 88032L605 | $720.8K | 208,333 | 0.1% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $41.9K | 4,675 | 0.0% |